SC134-deruxtecan, a fucosyl-GM1 targeting ADC for small cell lung cancer therapy
Bryony Heath(University of Nottingham), Mireille Vankemmelbeke(University of Nottingham)
Cited by 1
Related Papers
Monoclonal Antibody Targeting Sialyl-di-Lewisa–Containing Internalizing and Noninternalizing Glycoproteins with Cancer Immunotherapy Development Potential
|Molecular Cancer Therapeutics|2019|27
Monoclonal Antibodies Targeting LecLex-Related Glycans with Potent Antitumor Activity
|Clinical Cancer Research|2015|22
KATP channels: fact or artefact?: commentaries
|Cardiovascular Research|1994|3